Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease
Authors:
- 3 November 2020
- journal article
- review article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 88 (01) , 9-19
Abstract
Nonalcoholic fatty liver disease is a metabolic disorder characterized by lipid overloading in hepatocytes that can progress pathogenically and even end in hepatocellular carcinoma. Nonalcoholic fatty liver disease pharmacological treatment is still limited by unwanted side effects, whereas the use of food components with therapeutic potential is advisable. The culinary use of marine algae is traditional for some populations and reviving worldwide, with promising health outcomes due to the large number of bioactive compounds found in seaweeds. The present review focuses on brown-algae polysaccharides, particularly fucoidan, alginate, and laminarin, and summarizes the experimental evidence of their potential effects against nonalcoholic fatty liver disease onset and progression. In vitro and in vivo studies demonstrate that brown-algae polysaccharides exert beneficial actions on satiety feeling, caloric intake, fat absorption, and modulation of the gut microbiota, which could account for indirect effects on energy and lipid homeostasis, thus diminishing the fat overload in the liver. Specific effects against nonalcoholic fatty liver disease pathogenesis and worsening are also described and sustained by the antioxidant, anti-inflammatory, and antisteatotic properties of brown-algae polysaccharides. Further studies are required to clarify the mechanism of action of brown-algae polysaccharides on liver cells, to determine the composition and bioavailability of brown-algae polysaccharides present in different algal sources and to probe the clinical availability of these compounds in the form of algal foods, food supplements, and regulated therapeutics.Keywords
Funding Information
- Università degli Studi di Genova
This publication has 69 references indexed in Scilit:
- A Review on the Relationship Between Food Structure, Processing, and BioavailabilityCritical Reviews in Food Science and Nutrition, 2014
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences of the United States of America, 2013
- Fucanomics and Galactanomics: Marine Distribution, Medicinal Impact, Conceptions, and ChallengesMarine Drugs, 2012
- Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisWorld Journal of Gastroenterology, 2012
- Therapies from Fucoidan; Multifunctional Marine PolymersMarine Drugs, 2011
- Rising from the Sea: Correlations between Sulfated Polysaccharides and Salinity in PlantsPLOS ONE, 2011
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trialScandinavian Journal of Gastroenterology, 2009
- Fucoidan: Structure and BioactivityMolecules, 2008
- Human gut microbes associated with obesityNature, 2006